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RESEARCH ARTICLE

Open Access

Ocular and neural distribution of feline
herpesvirus-1 during active and latent
experimental infection in cats
Wendy M Townsend1,3*, Susan Jacobi1,4, Shih-Han Tai2,5, Matti Kiupel2, Annabel G Wise2 and Roger K Maes2

Abstract
Background: Herpes simplex virus 1 (HSV-1) and varicella zoster virus (VZV) cause extensive intra-ocular and neural
infections in humans and are closely related to Felid herpes virus 1 (FeHV-1). We report the extent of intra-ocular
replication and the extent and morphological aspects of neural replication during the acute and latent phases of
FeHV-1 infection. Juvenile, SPF cats were inoculated with FeHV-1. Additional cats were used as negative controls.
Cats were euthanized on days 6, 10, and 30 post-inoculation.
Results: FeHV-1 was isolated from the conjunctiva, cornea, uveal tract, retina, optic nerve, ciliary ganglion (CG),
pterygopalatine ganglion (PTPG), trigeminal ganglion (TG), brainstem, visual cortex, cerebellum, and olfactory bulb
of infected cats during the acute phase, but not the cranial cervical ganglion (CCG) and optic chiasm. Viral DNA
was detected in all tissues during acute infection by a real-time quantitative PCR assay. On day 30, viral DNA was
detected in all TG, all CCG, and 2 PTPG. Histologically mild inflammation and ganglion cell loss were noted within
the TG during acute, but not latent infection. Using linear regression, a strong correlation existed between clinical
score and day 30 viral DNA copy number within the TG.
Conclusions: The correlation between clinical score and day 30 viral DNA copy number suggests the severity of
the acute clinical infection is related to the quantity of latent viral DNA. The histologic response was similar to that
seen during HSV-1 or VZV infection. To the author’s knowledge this is the first report of FeHV-1 infection involving
intraocular structures and autonomic ganglia.
Keywords: Feline, Felid herpes virus1, FeHV-1, Latency, Ganglia, Eye

Background
Felid herpesvirus-1 (FeHV-1) is an enveloped dsDNA
virus classified under the genus Varicellovirus within the
subfamily Alphaherpesvirinae [1]. In susceptible cats,
FeHV-1 accounts for approximately 50-75% of upper
respiratory infections [2]. Following exposure of the conjunctival and oronasal mucous membranes, FeHV-1 replicates extensively at these sites, resulting in pyrexia,
depression, anorexia, sneezing, conjunctivitis, keratitis,
and oculonasal discharge [3]. The acute phase of FeHV* Correspondence: townsenw@purdue.edu
1
Department of Small Animal Clinical Sciences, College of Veterinary
Medicine, Michigan State University, D208 Veterinary Medical Center,
48824-1314 East Lansing, MI, USA
3
The current address: Department of Veterinary Clinical Sciences, Purdue
University, 47907-2026 W. Lafayette, IN, USA
Full list of author information is available at the end of the article

1 infection is followed by lifelong latency [4]. Latency is
defined as an asymptomatic period during which infectious virus cannot be recovered from tissues, but can be
induced to reactivate through organ culture or explantation [5,6]. Reactivation of a previously latent infection
occurs readily in response to natural stressors or administration of corticosteroids [4]. Reactivation is associated
with renewed virus production, shedding of infectious
virus, and ocular or nasal lesions [4].
In a murine herpes simplex virus 1 (HSV-1) model, the
spread of HSV-1 from initial corneal epithelial replication
sites to intra-ocular structures and the nervous system has
been well documented [7]. After topical inoculation of
scarified corneas of adult mice, viral antigen has been
detected using immunohistochemistry by day 6 in the cornea, conjunctiva, iris, choroid, retina, ciliary ganglia (CG),
trigeminal ganglia (TG), pterygopalatine ganglia (PTPG),
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superior cervical ganglia, brainstem, olfactory bulb, and
hypothalamus [7]. HSV-1 infection has also been documented in human CG [8]. Latent varicella zoster virus
(VZV) has been demonstrated in cranial nerve ganglia,
dorsal root ganglia, and autonomic nervous system ganglia of human cadavers using polymerase chain reaction
(PCR) and in situ hybridization [9-12]. The VZV has also
been isolated from corneas of humans with acquired
immunodeficiency syndrome and chronic keratitis [13].
Previous reports have shown that FeHV-1 can be isolated
during the acute phase of the disease from the cornea,
conjunctiva, nasal epithelium, nasal turbinates, tonsils,
and TG [14,15]. The presence of viral DNA during latency
has been demonstrated by PCR in the cornea, nasal
turbinates, olfactory bulbs, cerebrum, optic nerve, optic
chiasm, and TG [16-18]. Latency associated transcripts
(LATs), small strands of RNA transcribed by the virus
within latently infected neurons [5,6], have been shown to
be present within latently infected TG [18].
The TG or other neural tissues of FeHV-1 infected animals have not been examined histologically to document the lesions caused by FeHV-1 infection. In the TG
of mice acutely infected with HSV-1, the virus has been
detected within both neural and non-neural cells [19].
Infection with HSV-1 also induced apoptosis of neurons
and a histiocytic and lymphocytic infiltrate [20-22]. The
TG of mice latently infected with HSV-1 typically demonstrated a mononuclear cellular infiltrate that has also
been documented in the TG of latently infected humans
[23-28]. This cellular infiltrate is believed to play a critical role in the prevention of recrudescence [29].
In this study we defined the ocular and neural tissues
with detectable virus during active and latent FeHV-1 infection and quantified the amount of virus present within
the cornea, conjunctiva, TG, CG, PTPG, cranial cervical
ganglia (CCG), uvea, retina, optic nerve, optic chiasm, visual cortex, cerebellum, brainstem, and olfactory bulb. The
study population consisted of 3 groups each composed of
4 inoculated cats and 1 control cat. Samples were collected from group 1 on day 6 post inoculation (PI) when
all FeHV-1 exposed cats were exhibiting ocular signs,
from group 2 on day 10 PI which was the peak of ocular
and respiratory signs, and from group 3 on day 30 PI
when the clinical signs had resolved and latency was
established. The TG and CG were examined histologically
to detect lesions associated with both active and latent infection. Correlations between the severity of clinical signs
and the viral load within the TG were made from samples
collected on days 6, 10, and 30 post-inoculation.

Results
Clinical scores and serologic evaluation

All inoculated cats developed clinical signs such as sneezing, ocular discharge, nasal discharge, anorexia, and
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elevated body temperature that were consistent with
FeHV-1 infection, whereas all control cats remained
disease-free. The median total of the clinical scores from
day 0 to the day of euthanasia was 6 (range 4 to 8) for
group 1 (day 6 PI), 21 (range 17 to 28) for group 2 (day 10
PI), and 19.5 (range 17 to 32) for group 3 (day 30 PI). In
group 3 all clinical signs had resolved prior to euthanasia.
The control cats did not develop FeHV-1 specific virus
neutralizing (VN) antibodies. The group 3 inoculated cats
seroconverted as the FeHV-1 VN antibody titers were less
than 1:4 at days 7 and 14 PI and increased to 1:32 to 1:128
at days 21 and 30 PI.
Virus isolation (VI)

The VI data are presented in Table 1. FeHV-1 was not
isolated from any of the samples taken from the control
cats. Except for the cranial cervical ganglion, virus was
isolated from each of the tissue types collected from
group 1 (day 6 PI), group 2 (day 10 PI), or both. Except
for a single corneal sample from a cat in group 3 (cat
#11), virus was not isolated from any tissue sample collected from group 3 (day 30 PI).
RT-PCR

The PCR results for each individual tissue type and the
FeHV-1 DNA copy numbers reported per 100 cells of
the homogenized tissues examined are shown in Table 2
and Figure 1. As the number of FeHV-1 genomes/μg of
sample DNA was known, the FeHV-1 copy number per
100 cells was calculated based on 260,000 haploid genome equivalents/μg of feline cellular DNA [30]. Individual cell types were not examined. The FeHV-1 copy
number per 100 cells was reported to standardize comparisons between the various tissues as different tissues
yielded different amounts of DNA. FeHV-1 DNA was
not detected by real-time PCR in any of the samples
obtained from the control cats. For each group, the total
of the clinical scores from Day 0 to the day of euthanasia
and the FeHV-1 DNA copy number per 100 cells in the
TG were compared by linear regression (Figure 2). The
total clinical score and FeHV-1 copy number were
strongly correlated (p=0.021, R2=0.9583) for group 3.
The clinical score and FeHV-1 copy number were not
correlated for groups 1 (p=0.39, R2=0.37) or 2 (p=0.41,
R2=0.36).
Histopathology

The corneas, conjunctiva, TG, and CG were examined
histologically. No histological changes were found within
the cornea, conjunctiva, TG, or CG of control animals.
No histologic changes were noted within any of the
corneal samples except for one cat from group 2. In that
sample multiple, solitary, degenerate epithelial cells and
a mild lymphocytic infiltrate were noted. Histologic
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Table 1 Virus isolation results
Tissue

Group 1
(Day 6)

Group 2
(Day 10)

Group 3
(Day 30)

(# pos/ #
tested)

(# pos/ #
tested)

(# pos/ #
tested)

Cornea

4/4

4/4

1/4

Conjunctiva

4/4

4/4

0/4

Trigeminal ganglia

2/4

2/4

0/4

Ciliary ganglia

2/4

2/4

0/4

PTPG

4/4

3/4

0/4

CCG

0/4

0/4

0/4

Uvea

4/4

4/4

0/4

Retina

4/4

4/4

0/4

Optic nerve

3/4

1/4

0/4

Optic chiasm

3/4

0/4

0/4

Visual cortex

4/4

1/4

0/4

Cerebellum

3/4

3/4

0/4

Brainstem

3/4

2/4

0/4

Olfactory bulb

4/4

2/4

0/4

Virus isolation results obtained for each tissue type on each day. All control
samples were negative and are not listed within this table. PTPG
pterygopalatine ganglia. CCG cranial cervical ganglia.

changes consisting of epithelial cell attenuation and/or
loss and lymphoplasmacytic inflammation were seen in
the conjunctival samples from all 12 inoculated cats.
The changes were milder in the group 3 cats. All 4/4
TG obtained from group 1 and 3/4 obtained from group

2 had histologic changes consisting of ganglion cell death,
depletion of ganglionic cells, increased numbers of glial
cells, and lymphoplasmacytic inflammation (Figure 3).
One/four TG obtained from group 3 showed ganglion cell
depletion, but no concurrent inflammation. Histologic
changes were not evident in the examined CG of inoculated cats. However in 3 cats the small size of the CG
precluded obtaining an appropriate section for histologic
evaluation.

Discussion
FeHV-1 infection in cats is a valid natural host model to
study herpesvirus-induced ocular disease and latency in
humans. In this study we describe intra-ocular and
neural FeHV-1 involvement during the acute phase of
the infection of tissues (CG, PTPG, CCG, uvea, and retina) from which FeHV-1 has not previously been isolated [14-18]. During the latent phase of infection, latent
viral DNA was detected not only within the TG, but also
the CCG of all cats and in PTPG of two of the inoculated cats. Morphologically ganglionic cell death and inflammation were present within the TG during the acute
phase of infection.
To our knowledge, involvement of the uveal tract during the acute phase of FeHV-1 infection has not previously been documented. Felid herpesvirus-1 DNA has
been detected by PCR in the aqueous humor of cats with
idiopathic uveitis and in clinically normal cats [31].
However, in previous studies only the uveal tract of latently infected cats has been examined and virus was

Table 2 Real time PCR assay results
Group 1 (Day 6)
Tissue

RT-PCR
(#pos/# tested)

Group 2 (Day 10)
Average FeHV-1 DNA
copies/100 cells

RT-PCR

Group 3 (Day 30)
FeHV-1/100 cells

(#pos/# tested)

RT-PCR

FeHV-1/100 cells

(#pos/# tested)

Cornea

4/4

3915

4/4

1450

1/4

49

Conjunctiva

4/4

6950

4/4

1168

1/4

<1

TG

4/4

106

4/4

262

4/4

93

CG

4/4

65

4/4

409

1/4

1

PTPG

4/4

410

4/4

197

2/4

14

CCG

3/4

1

4/4

4

4/4

3

Uvea

4/4

533

4/4

21

0/4

0

Retina

4/4

2

4/4

4

0/4

0

Optic nerve

4/4

35

4/4

11

1/4

<1

Op chiasm

4/4

<1

4/4

2

0/4

0

Vis cortex

4/4

<1

2/4

<1

0/4

0

Cerebellum

4/4

1

4/4

<1

0/4

0

Brainstem

3/4

3

2/4

<1

0/4

0

Olf bulb

4/4

9

4/4

4

0/4

0

Real-time PCR assay (RT-PCR) results obtained for each tissue type on each day. All control samples were negative and are not listed within this table. TG
trigeminal ganglia. CG ciliary ganglia. PTPG pterygopalatine ganglia. CCG cranial cervical ganglia. Op chiasm optic chiasm. Vis cortex visual cortex. Olf bulb
olfactory bulb.
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Figure 1 FeHV-1 copy number versus days post inoculation.
The average number of copies of FeHV-1 genome per 100 cells was
plotted against the days post inoculation. The FeHV-1 copy number
decreases over time in most tissues sampled. However, the ciliary
ganglia, trigeminal ganglia, cranial cervical ganglia, and optic chiasm
had higher levels of virus present at day 10 than at day 6.

not detected [17]. The isolation of FeHV-1 from the
uveal tract demonstrates that cats, like mice infected
with HSV-1 [32], experience active intra-ocular virus
replication.
Another not previously reported finding was the isolation of FeHV-1 from all retinas during the acute phase
of the disease. As retinal homogenates were used in the
current study, we were unable to determine the specific
layer of the retina involved during the acute phase of infection. In one murine model HSV-1 study, utilizing
corneal scarification prior to inoculation, infectious virus
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was detected within the retinal photoreceptors [33]. Noteworthy also is that after intracameral administration of
HSV-1 in a murine HSV-1 model, the virus is detected
within the contralateral, but not the ipsilateral retina [34].
In the present study, FeHV-1 reached the retina without
intracameral injection or corneal scarification. No visual
deficits were noted. However fundic examinations were
not performed as part of this study and therefore retinal
abnormalities might not have been detected. In addition,
histologic examination was not performed on any of the
intra-ocular tissues. Therefore while FeHV-1 was detected
within multiple ocular tissues, the morphological changes
due to the presence of the virus were not evaluated.
In the murine HSV-1 model an intense inflammatory
response is noted histologically in response to the intraocular infection [33,34]. In contrast, the cats in this
study showed no clinical signs of intraocular inflammation despite the presence of relatively large amounts of
replicating virus. Perhaps the magnitude of the infection
(8–14 times less virus in the intra-ocular tissues compared with the cornea and conjunctiva) explains the lack
of intra-ocular inflammation noted in this study. The
amount of FeHV-1 present within the intra-ocular tissues
is much less than the 2×104 plaque forming units used to
inoculate the anterior chamber in the murine model [34].
Ocular examination with a slit-lamp biomicroscope would
be required in future studies to detect subtle inflammation. Future studies combining histologic examination and
in situ hybridization will further clarify this difference.
Virus particles and FeHV-1 DNA were detected during
this study within the optic nerve and optic chiasm. Since
these tissues lack neuronal cell bodies [35] the virus
must either have been undergoing axonal transport [35],
have infected glial cells within the optic nerve and chiasm [36], or have been present within leukocytes within
the neural tissues [37]. Reubel et al. [16] and Weigler
et al. [17] have previously detected latent FeHV-1 DNA
within the optic nerves and chiasms using PCR assays.
In this study latent viral DNA was not detected within
optic chiasm homogenates. Viral FeHV-1 DNA, but not
infectious virus, was present in the optic nerve of one
cat. However in this cat virus was isolated from the cornea making it difficult to conclude that the DNA present
in the optic nerve was latent.
FeHV-1 was also detected within the ciliary, pterygopalatine, and cranial cervical autonomic ganglia examined in this study. Involvement of the autonomic
ganglia has not previously been associated with FeHV-1
infection. In this study FeHV-1 established latent infections within the CCG of all cats. The consistent presence of latent FeHV-1 within the CCG is similar to the
behavior of varicella zoster virus (VZV), also a member
of the Varicellovirus genus, which is consistently found
not only in cranial nerve ganglia [9,10], but also in
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Total Clinical Score for Group 3 from day 0 to day of euthanasia

Figure 2 Clinical score versus FeHV-1 copy number within the trigeminal ganglia (TG). Linear regression of the total clinical score for
group 3 from day 0 to the day of euthanasia compared to the FeHV-1 copy number per 100 cells within the TG. A close linear relationship was
seen between the amount of latent virus present within the TG and the total clinical score for each individual animal in group 3. The p-value was
0.021 and R2 was 0.9583.

autonomic systemic ganglia [12]. In contrast, HSV-1 latency in humans is restricted to cranial nerve ganglia
[38,39]. Infection of the autonomic ganglia provides extensive neural connection from the nasal passages and
oropharynx to the ocular surface and intra-ocular structures [40]. These neural pathways have been well described by Labetoulle [32]. Latency within the autonomic
ganglia as well as the TG may results in herpetic ocular
disease which could involve not only the cornea, but also
the uveal tract and retina [41].
Histologically the CG examined all appeared normal.
Therefore either inflammatory changes do not occur in
the CG or they were very focal and missed on histological sectioning. In contrast, all of the TG collected at
days 6 and 10 PI showed ganglionic cell death, depletion
of ganglion cells, increased numbers of glial cells, and
lymphoplasmacytic inflammation. In human patients
with HSV-1 infection histologic examination of the ganglia has not been performed during active infection due

Figure 3 Histologic section of the trigeminal ganglion.
Hematoxylin and eosin stained section of the trigeminal ganglion
taken at 400X magnification. Note the lymphoplasmacytic
inflammation surrounding the neurons.

to the obvious difficulty in obtaining tissue samples [42].
However in the murine model of HSV-1 infection, apoptosis of neurons and histiocytic and lymphocytic infiltrates have been noted [20-22]. In humans infected with
VZV, neuritis and degeneration of sensory nerve roots
have been noted [43,44]. In this study, only one section
of TG from group 3 showed histologic changes: a loss of
ganglion cells, but no concurrent inflammation. This
was an unexpected finding as mice latently infected with
HSV-1 typically demonstrate a mononuclear cellular infiltrate [23-27]. In human TG, latent HSV-1 infection
has also been associated with chronic inflammation. A
lymphocytic infiltrate has also been noted in bovine TG
latently infected with bovine herpesvirus −1 (BHV-1)
[45]. Interestingly in one study, lymphocytes consistently surrounded latently infected HSV-1 human TG
neurons, but not the VZV-positive neurons [28]. Latent
FeHV-1 infection may be more similar to latent VZV in
this aspect.
In the current study, the FeHV-1 copy numbers in the
TG were much higher than those previously reported
[30]. This may be due to the fact that the time frame of
this study was 30 days versus 56 days in the previous
study. This may also be due to differences in the virulence of the viral strains used in each study, C-27 versus
SGE [30]. The strain of HSV-1 has been shown to influence the number of latent virus particles within individual neurons in a murine model [46]. The amount of
virus inoculated was higher in the previous study of
FeHV-1 [30] than this study and therefore was unlikely
to play a role in the increased copy numbers within the
TG. Based on studies of HSV-1, latency is typically
established in only a small percentage of sensory neurons in humans [47] and the copy number is usually
only 2–50 copies/cell [47,48]. The copy numbers are reportedly similar for VZV [49,50]. Interestingly in our
study wide variation was seen in the amount of latent
FeHV-1 DNA detected despite all individuals receiving
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the same initial inoculum. In one study of a rabbit model
of HSV-1, the number of viral genomes was directly proportional to the titer of infectious inoculum [51]. However in a different rabbit model and also murine model,
this did not hold true [52,53]. In the study reported here
the latent viral load was strongly associated with the severity of clinical signs as denoted by the total clinical
score from day 0 to the day of euthanasia. For mice
infected with HSV-1, a higher latency load is associated
with an increased risk of recurrence [54]. In human patients with HSV-1 and HSV-2 infection, the severity of
the first episode and the latency load are strongly linked
to the recurrence rate [55]. This data would imply that
animals with more severe clinical signs were at higher
risk for recrudescence.

Conclusions
The intra-ocular and neural involvement during FeHV-1
infection was more widespread than previously known.
Autonomic ganglia as well as sensory ganglia harbored
latent FeHV-1. The histologic response in neural tissue
was similar to that seen during HSV-1 or VZV infection.
Finally increased severity of clinical signs was associated
with increased latent viral loads, likely increasing the risk
of recrudescent infection.
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scoring system modified from the USDA Supplemental
Assay Method 311 (Table 3) [56].
Serologic examination

All cats were determined to be serologically negative for
FeHV-1 virus neutralizing antibodies prior to inoculation.
Blood samples were collected for evaluation of FeHV-1
VN antibodies using a modified microtiter neutralization
assay [57,58] on days 7, 14, and 21 post-inoculation from
the cats euthanized on day 30 (group 3).
Sample collection

Groups of 4 inoculated cats and 1 control cat were euthanized with an intravenous injection of pentobarbital
sodium on day 6 PI when all FeHV-1 exposed cats were
exhibiting ocular signs (group 1), on day 10 PI corresponding to peak ocular and respiratory signs (group 2),
and on day 30 PI when the clinical signs had resolved
and latency was established (group 3). Using sterile technique the entire right conjunctiva, cornea, uveal tract,
retina, optic nerve, entire optic chiasm, CG, PTPG,
CCG, TG, brainstem, visual cortex, cerebellum, and olfactory bulb were placed in individual Eppendorf tubes
and frozen at –80°C. Gloves were changed and the
Table 3 Clinical scoring system

Methods
Animals

All experiments were performed in full compliance with
the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and with approval from the
Michigan State University Animal Care and Use Committee. A total of fifteen 6-month-old female specific
pathogen free (SPF) cats were obtained from a commercial vendor (Liberty Research, Inc, Waverly, NY). Cats
were housed in individual cages with the infected and
control groups in separate containment rooms (Biocontainment Level-2) with controlled temperature, humidity, and lighting. All personnel wore sterile disposable
Tyvek coveralls, gloves, head covers, and shoes covers
upon entering a containment room. Cats were fed a
combination of dry and moist diets. All cats were acclimated for 7 days before virus exposure.
Inoculation and clinical scores

Cats were anesthetized via chamber administration of
halothane and oxygen. Twelve cats were infected by instilling 1.05 ml (1×105 TCID50/ml) of the C-27 strain of
FeHV-1 (ATCC, Manassas, VA) into the left and right
conjunctival sacs (350 μl each), external nares (150 μl
each), and oropharynx (50 μl). The other 3 cats served
as controls. Animals were observed and clinical scores
assigned daily to each cat by one of two trained observers after at least 15 minutes of observation using a

Clinical sign

Daily score if present

Fever
103.0 to 103.9°F

1

104.0 to 104.9°F

2

≥105°F

3

Conjunctivitis/Ocular discharge

1

Rhinitis/Nasal discharge

1

Sneezing

1

Audible rales

2

Coughing

2

Open mouth breathing

3

Anorexia

1

Dehydration

1

Hypothermia < 99°F

2

Oral ulcers (lingual or oral mucosa)
1 ulcer <4 mm

1

Multiple ulcers <4 mm

3

Ulcer or ulcers >4 mm

5

Salivating

1

External ulcers (lip or nares)
Non-bleeding ulcer

4

Bleeding ulcer

6

The following scoring system was modified from the published USDA Scoring
Method for FeHV-1 [56] and was used to assign daily clinical scores for each
cat. The highest possible score for a cat on any given day was 31.
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instruments flamed with ethanol between each collection site. To each Eppendorf tube, 800 μl of Bovarnick’s
solution and sterile homogenizing beads were added.
The Eppendorf tube was then placed in the mixer mill
(MM300, Qiagen, Valencia, CA) for tissue disruption
and homogenization. The resulting homogenate was frozen at –80°C. Sections of the contralateral cornea and
conjunctiva and the entire contralateral TG and CG
were collected for histological evaluation.
Virus isolation

A 200 μl aliquot of each tissue’s homogenate was reserved for DNA extraction. The remaining suspension
was brought to 3 ml with Eagle’s Minimum Essential
Medium (EMEM), supplemented with 10% fetal bovine
serum. From the homogenate, 500 μl aliquots of filtered
(0.45 μm) tissue extracts were inoculated onto monolayers
of Crandell Reese feline kidney (CRFK) cells grown onto
24-well plates. The inoculated cells were examined daily
for the appearance of characteristic cytopathic effects. Viral
isolates were verified to be FeHV-1 by direct immunofluorescence (application of direct polyclonal FeHV-1 fluorescent antibody) (American BioResearch, Pullman, WA).
Virus isolation attempts were performed in duplicate.
SYBR green-based real-time quantitative PCR

DNA extraction was performed utilizing the Qiagen
DNEasy Blood and Tissue kit (Qiagen, Valencia, CA).
DNA quantitation was performed spectrophotometrically.
Negative extraction controls consisted of 200 μl of PBS.
The real-time quantitative SYBR Green PCR assay
targeted a 478 bp fragment containing the FeHV-1 gE
gene. The sequence of the forward primer was 5′-GGT
CAT GTG TAA TGT TGA CG-3′, and the sequence of
the reverse primer was 5′- GTC TTT GGT TCT GAT
GAG AG-3′ [56]. The sensitivity of this assay was 10
genomic copies of FeHV-1. Its dynamic range was confirmed by its ability to amplify the targeted DNA fragment of 48 known clinical isolates of FeHV-1.
The amplification kit used was the Quantitect SYBR
Green PCR Kit (QIAGEN, Valencia, CA) with a final primer concentration of 0.5 μM. The 50 μl real time PCR reaction mixture consisted of 25 μl 2× SYBR Green mix
(QIAGEN, Valencia, CA), 1 μl forward primer (25 pmol/μl),
1 μl reverse primer (25 pmol/μl), 100 ng of template DNA
(20 ng of template DNA for CG and pterygopalatine
ganglia) and ddH2O. Real-time PCR was performed on a
iCycler™ iQ® System (Bio-Rad Laboratories, Hercules, CA)
with the following cycling conditions: pre-denaturation at
95°C for 15 min, followed by 45 cycles of 94°C for 30 sec,
50°C for 30 sec and 72°C for 1 min. A post-amplification
melt curve analysis was incorporated in the run to confirm the specificity of the amplicons generated. Post-
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PCR analysis was performed using the iCycler detection
software version 1.1.
All reactions were conducted in duplicate. The DNA
extraction controls and PCR reagent controls were included in each run. A standard curve of threshold cycle
in relation to viral copy number was constructed. The
standard curve for FeHV-1 was generated by a series of
10-fold dilutions (10-1 – 10-6 copies) of purified FeHV-1
stock DNA. Samples for the standard curve were assayed
in triplicate for each run and also served as the positive
control. As the number of FeHV-1 genomes/μg of ganglionic DNA was known, the FeHV-1 copy number per
100 cells was calculated based on 260,000 haploid genome equivalents/μg of feline cellular DNA [30].
Histopathology

Following fixation in 10% buffered formalin, the conjunctiva, cornea, TG, and CG were paraffin-embedded,
sectioned at a thickness of 5 μm, and stained with
hematoxylin and eosin. Samples were examined by light
microscopy by a single board-certified veterinary pathologist (MK).
Statistical evaluation

Linear regression was performed to compare the total of
the clinical scores from Day 0 to the day of euthanasia
and the FeHV-1 copy number within the TG in groups
1, 2, and 3. Significance was set at p<0.05.
Abbreviations
FeHV-1: Felid herpesvirus 1; BHV-1: Bovine herpesvirus 1; CCG: Cranial cervical
ganglion; CG: Ciliary ganglion; HSV-1: Herpes simplex virus 1; PI: Postinoculation; PTPG: Pterygopalatine ganglion; RT-PCR: Real time polymerase
chain reaction assay; TG: Trigeminal ganglion; VI: Virus isolation; VN: Virus
neutralizing; VZV: Varicella zoster virus.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
WMT conceived of the study, participated in its design, coordinated the
study, performed sample collection, performed the statistical evaluation, and
drafted the manuscript. SJ assisted with study design, performed daily
clinical scoring, performed sample collection, performed the RT-PCR, and
helped to draft the manuscript. SHT assisted with study design, performed
the virus isolation, and performed the RT-PCR. MK performed the histologic
review of the specimens. AW assisted with study design, assisted with study
coordination, assisted with virus isolation, and assisted with RT-PCR. RKM
jointly conceived of the study, participated in its design, prepared the
inoculum, oversaw the virus isolation, and oversaw the RT-PCR. All authors
read and approved the final manuscript.
Authors’ information
WMT and SJ are Diplomates of the American College of Veterinary
Ophthalmologists. SHT completed his PhD in Comparative Medicine and
Integrative Biology with a thesis entitled “The complete and annotated
genomic sequence of feline herpesvirus 1 (FHV-1) and an infectious BAC clone: a
platform for studies of targeted mutants by recombineering.” MK is a Diplomate
of the American College of Veterinary Pathologists and serves as the head of
the histopathology and immunohistochemistry laboratory at the Michigan
State University Diagnostic Center for Population and Animal Health. AW is
an academic specialist in virology. RKM is a professor in the department of

Townsend et al. BMC Veterinary Research 2013, 9:185
http://www.biomedcentral.com/1746-6148/9/185

Page 8 of 9

microbiology and molecular genetics, serves as the section chief for virology,
and has a specific research focus on FeHV-1.
19.
Acknowledgements
The authors would like to acknowledge the assistance of Dr. John Kruger in
study design and Marlee Richter and Neal Wasserman for their assistance
with inoculation of animals, daily clinical scoring, and sample collection.
Funding was provided by the Michigan State University Companion Animal
Fund.
Author details
1
Department of Small Animal Clinical Sciences, College of Veterinary
Medicine, Michigan State University, D208 Veterinary Medical Center,
48824-1314 East Lansing, MI, USA. 2Diagnostic Center for Population and
Animal Health, Michigan State University, 4125 Beaumont Road, 48910-8104
Lansing, MI, USA. 3The current address: Department of Veterinary Clinical
Sciences, Purdue University, 47907-2026 W. Lafayette, IN, USA. 4The current
address: Animal Eye Care, 1612 Washington Blvd, 94539 Fremont, CA, USA.
5
The current address: National Cancer Institute, Bldg. 535, Room 324, 1050
Boyles St., PO Box B21702 Frederick, MD, USA.

20.

21.

22.

23.

24.

Received: 11 June 2013 Accepted: 18 September 2013
Published: 22 September 2013
25.
References
1. Pomeranz LE, Reynolds AE, Hengartner CJ: Molecular biology of
pseudorabies virus: impact on neurovirology and veterinary medicine.
Microbiol Mol Biol Rev 2005, 69:462–500.
2. Nasisse M: Feline herpesvirus ocular disease. Vet Clin N Am - Small 1990,
20:667–680.
3. Gaskell R, Dawson S, Radford A, Thiry E: Feline herpesvirus. Vet Res 2007,
38:337–354.
4. Gaskell R, Povey M: Experimental induction of feline viral rhinotracheitis
re-excretion in FVR-recovered cats. Vet Rec 1977, 100:128–133.
5. Stroop W, Baringer J: Persistent, slow and latent viral infections. Prog Med
Virol 1982, 28:1–43.
6. Stevens JG, Cook ML: Latent infections induced by herpes simplex
viruses. Cancer Res 1973, 33:1399–1401.
7. Martin JR, Jenkins FJ, Henken DB: Targets of herpes simplex virus type 1
infection in a mouse corneal model. Acta Neuropathol 1991, 82:353–363.
8. Bustos DE, Atherton SA: Detection of herpes simplex virus type 1 in
human ciliary ganglia. Invest Ophth Vis Sci 2002, 43:2244–22492.
9. Gilden DH, Vafai A, Shtram Y, Becker Y, Devlin M, Wellish M: Varicella-zoster
virus DNA in human sensory ganglia. Nature 1983, 306:478–480.
10. Hyman RW, Ecker JR, Tenser RB: Varicella-zoster virus RNA in human
trigeminal ganglia. Lancet 1983, 2:814–816.
11. Mahalingam R, Wellish M, Wolf W, Dueland AN, Cohrs R, Vafai A, Gilden D:
Latent varicella-zoster viral DNA in human trigeminal and thoracic
ganglia. N Engl J Med 1990, 323:627–631.
12. Gilden DH, Gesser R, Smith J, Wellish M, Laguardia JJ, Cohrs RJ, Mahalingam
R: Presence of VZV and HSV-1 DNA in human nodose and celiac ganglia.
Virus Genes 2001, 23:145–147.
13. Chern KC, Conrad D, Holland GN, Holsclaw DS, Schwartz LK, Margolis TP:
Chronic varicella-zoster virus epithelial keratitis in patients with acquired
immunodeficiency syndrome. Arch Ophthalmol 1998, 116:1011–1017.
14. Nasisse MP, Guy JS, Davidson MG, Sussman WA, Fairley NM: Experimental
ocular herpesvirus infection in the cat. Sites of virus replication, clinical
features and effects of corticosteroid administration. Invest Ophth Vis Sci
1989, 30:1758–1768.
15. Hoover EA, Rohovsky MW, Griesemer RA: Experimental feline viral
rhinotracheitis in the germfree cat. Am J Pathol 1970, 58:269–282.
16. Reubel GH, Ramos RA, Hickman MA, Rimstad E, Hoffmann DE, Pedersen NC:
Detection of active and latent feline herpesvirus 1 infections using the
polymerase chain reaction. Arch Virol 1993, 132:409–420.
17. Weigler B, Babineau C, Sherry B, Nasisse M: High sensitivity polymerase
chain reaction assay for active and latent feline herpesvirus-1 infections
in domestic cats. Vet Rec 1997, 140:335–338.
18. Townsend WM, Stiles J, Guptill-Yoran L, Krohne SG: Development of a
reverse transcriptase-polymerase chain reaction assay to detect feline
herpesvirus-1 latency-associated transcripts in the trigeminal ganglia

26.

27.

28.

29.

30.

31.

32.

33.

34.

35.

36.

37.
38.
39.
40.
41.

and corneas of cats that did not have clinical signs of ocular disease.
Am J Vet Res 2004, 65:314–319.
Dosa S, Castellanos K, Bacsa S, Gagyi E, Kovacs SK, Valyi-Nagy K, Shukla D,
Dermody TS, Valyi-Nagy T: Chronic progressive deficits in neuron size,
density and number in the trigeminal ganglia of mice latently infected
with herpes simplex virus. Brain Pathol 2011, 21:583–593.
Geiger KD, Nash TC, Sawyer S, Krahl T, Patstone G, Reed JC, Krajewski S,
Dalton D, Buchmeier MJ, Sarvetnick N: Interferon-gamma protects against
herpes simplex virus type 1-mediated neuronal death. Virology 1997,
238:189–197.
Henken DB, Goldstein ME, Martin JR: Herpes simplex virus type-2 infection
by a footpad route results in neuronal death in mouse spinal ganglia.
J Neurol Sci 1993, 115:177–183.
Perng GC, Jones C, Ciacci-Zanella J, Stone M, Henderson G, Yukht A, Slanina
SM, Hofman FM, Ghiasi H, Nesburn AB, Wechsler SL: Virus-induced
neuronal apoptosis blocked by the herpes simplex virus latencyassociated transcript. Science 2000, 287:1500–1503.
Cantin EM, Hinton DR, Chen J, Openshaw H: Gamma interferon expression
during acute and latent nervous system infection by herpes simplex
virus type 1. J Virol 1995, 69:4898–4905.
Chen SH, Garber DA, Schaffer PA, Knipe DM, Coen DM: Persistent elevated
expression of cytokine transcripts in ganglia latently infected with
herpes simplex virus in the absence of ganglionic replication or
reactivation. Virology 2000, 278:207–216.
Halford WP, Gebhardt BM, Carr DJ: Persistent cytokine expression in
trigeminal ganglion latently infected with herpes simplex virus type 1.
J Immunol 1996, 157:3542–3549.
Khanna KM, Bonneau RH, Kinchington PR, Hendricks RL: Herpes simplex
virus-specific memory CD8+ T cells are selectively activated and retained
in latently infected sensory ganglia. Immunity 2003, 18:593–603.
Liu T, Khanna KM, Chen X, Fink DJ, Hendricks RL: CD8(+) T cells can block
herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory
neurons. J Exp Med 2000, 191:1459–1466.
Theil D, Derfuss T, Paripovic I, Herberger S, Meinl E, Schueler O, Strupp M,
Arbusow V, Brandt T: Latent herpesvirus infection in human trigeminal
ganglia causes chronic immune response. Am J Pathol 2003, 163:2179–2184.
Knickelbein JE, Khanna KM, Yee MB, Baty CJ, Kinchington PR, Hendricks RL:
Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1
reactivation from neuronal latency. Science 2008, 322:268–271.
Sussman MD, Maes RK, Kruger JM: Vaccination of cats for feline
rhinotracheitis results in a quantitative reduction of virulent feline
herpesvirus-1 latency load after challenge. Virology 1997, 228:379–382.
Maggs D-J, Lappin M-R, Nasisse M-P: Detection of feline herpesvirusspecific antibodies and DNA in aqueous humor from cats with or
without uveitis. Am J Vet Res 1999, 60:932–936.
Labetoulle M, Kucera P, Ugolini G, Lafay F, Frau E, Offret H, Flamand A:
Neuronal propagation of HSV1 from the oral mucosa to the eye.
Invest Ophth Vis Sci 2000, 41:2600–2606.
Carr DJ, Chodosh J, Ash J, Lane TE: Effect of anti-CXCL10 monoclonal
antibody on herpes simplex virus type 1 keratitis and retinal infection.
J Virol 2003, 77:10037–10046.
Whittum JA, McCulley JP, Niederkorn JY, Streilein JW: Ocular disease
induced in mice by anterior chamber inoculation of herpes simplex
virus. Invest Ophth Vis Sci 1984, 25:1065–1073.
LaVail JH, Tauscher AN, Sucher A, Harrabi O, Brandimarti R: Viral regulation
of the long distance axonal transport of herpes simplex virus
nucleocapsid. Neuroscience 2007, 146:974–985.
LaVail JH, Tauscher AN, Aghaian E, Harrabi O, Sidhu SS: Axonal transport
and sorting of herpes simplex virus components in a mature mouse
visual system. J Virol 2003, 77:6117–6126.
Tham KM, Studdert MJ: Clinical and immunological responses of cats to
feline herpesvirus type 1 infection. Vet Rec 1987, 120:321–326.
Bastian FO, Rabson AS, Yee CL, Tralka TS: Herpesvirus hominis: isolation
from human trigeminal ganglion. Science 1972, 178:306–307.
Baringer JR, Swoveland P: Recovery of herpes-simplex virus from human
trigeminal ganglions. N Engl J Med 1973, 288:648–650.
Pollock RVH: The Eye. In Miller’s anatomy of the dog. 2nd edition. Edited by
Evans HE, Christensen GC. Philadelphia: W.B.Saunders Company; 1979:1118.
Labetoulle M, Maillet S, Efstathiou S, Dezelee S, Frau E, Lafay F: HSV1
Latency sites after inoculation in the lip: assessment of their localization
and connections to the eye. Invest Ophth Vis Sci 2003, 44:217–225.

Townsend et al. BMC Veterinary Research 2013, 9:185
http://www.biomedcentral.com/1746-6148/9/185

Page 9 of 9

42. Mitchell BM, Bloom DC, Cohrs RJ, Gilden DH, Kennedy PG: Herpes simplex
virus-1 and varicella-zoster virus latency in ganglia. J Neurovirol 2003,
9:194–204.
43. Head H, Campbell A: The pathology of herpes zoster and its bearing on
sensory localization. Brain 1900, 23:353–523.
44. Denny-Brown D, Adams R, Fitzgerald P: Pathologic features of herpes zoster:
a note on “geniculate herpes”. Arch Neurol Psychiatry 1944, 51:216–231.
45. Winkler MT, Doster A, Sur JH, Jones C: Analysis of bovine trigeminal
ganglia following infection with bovine herpesvirus 1. Vet Microbiol 2002,
86:139–155.
46. Sawtell NM, Poon DK, Tansky CS, Thompson RL: The latent herpes simplex
virus type 1 genome copy number in individual neurons is virus strain
specific and correlates with reactivation. J Virol 1998, 72:5343–5350.
47. Wang K, Lau TY, Morales M, Mont EK, Straus SE: Laser-capture
microdissection: refining estimates of the quantity and distribution of
latent herpes simplex virus 1 and varicella-zoster virus DNA in human
trigeminal ganglia at the single-cell level. J Virol 2005, 79:14079–14087.
48. Cai GY, Pizer LI, Levin MJ: Fractionation of neurons and satellite cells from
human sensory ganglia in order to study herpesvirus latency. J Virol
Methods 2002, 104:21–32.
49. Mahalingam R, Wellish M, Lederer D, Forghani B, Cohrs R, Gilden D:
Quantitation of latent varicella-zoster virus DNA in human trigeminal
ganglia by polymerase chain reaction. J Virol 1993, 67:2381–2384.
50. Pevenstein SR, Williams RK, McChesney D, Mont EK, Smialek JE, Straus SE:
Quantitation of latent varicella-zoster virus and herpes simplex virus
genomes in human trigeminal ganglia. J Virol 1999, 73:10514–10518.
51. Perng GC, Ghiasi H, Slanina SM, Nesburn AB, Wechsler SL: High-dose ocular
infection with a herpes simplex virus type 1 ICP34.5 deletion mutant
produces no corneal disease or neurovirulence yet results in wild-type
levels of spontaneous reactivation. J Virol 1996, 70:2883–2893.
52. O’Neil JE, Loutsch JM, Aguilar JS, Hill JM, Wagner EK, Bloom DC: Wide
variations in herpes simplex virus type 1 inoculum dose and latencyassociated transcript expression phenotype do not alter the establishment
of latency in the rabbit eye model. J Virol 2004, 78:5038–5044.
53. Halford WP, Schaffer PA: Optimized viral dose and transient
immunosuppression enable herpes simplex virus ICP0-null mutants to
establish wild-type levels of latency in vivo. J Virol 2000, 74:5957–5967.
54. Hoshino Y, Pesnicak L, Dowdell KC, Burbelo PD, Knipe DM, Straus SE, Cohen
JI: Protection from herpes simplex virus (HSV)-2 infection with
replication-defective HSV-2 or glycoprotein D2 vaccines in
HSV-1-seropositive and HSV-1-seronegative guinea pigs. J Infect Dis 2009,
200:1088–1095.
55. Benedetti J, Corey L, Ashley R: Recurrence rates in genital herpes after
symptomatic first-episode infection. Ann Intern Med 1994, 121:847–854.
56. Sussman MD, Maes RK, Kruger JM, Spatz SJ, Venta PJ: A feline herpesvirus-1
recombinant with a deletion in the genes for glycoproteins gI and gE is
effective as a vaccine for feline rhinotracheitis. Virology 1995, 214:12–20.
57. Spatz SJ, Rota PA, Maes RK: Identification of the feline herpesvirus type 1
(FHV-1) genes encoding glycoproteins G, D, I and E: expression of FHV-1
glycoprotein D in vaccinia and raccoon poxviruses. J Gen Virol 1994,
75(Pt 6):1235–1244.
58. Kruger JM, Sussman MD, Maes RK: Glycoproteins gI and gE of feline
herpesvirus-1 are virulence genes: safety and efficacy of a gI-gE- deletion
mutant in the natural host. Virology 1996, 220:299–308.
doi:10.1186/1746-6148-9-185
Cite this article as: Townsend et al.: Ocular and neural distribution of
feline herpesvirus-1 during active and latent experimental infection in
cats. BMC Veterinary Research 2013 9:185.

Submit your next manuscript to BioMed Central
and take full advantage of:
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at
www.biomedcentral.com/submit

